Subject: Re: Examples needed against Soft Patents
From: "Stephen J. Turnbull" <>
Date: Wed, 22 Dec 2004 16:25:25 +0900

>>>>> "Michael" == Michael R Bernstein <> writes:

    Michael> Doesn't that make open peer-review *more* important for
    Michael> pharmaceuticals?

Not particularly.  According to Steve McConnell, "open" (ie, "I'll
look at it if and when I feel like it") peer review can't hold a
candle to review by a team of expert professionals.  This is going to
hold even more true for medical experiments.  Making it open (ie,
requiring publication of the patent application as well as the patent
awarded) is very unlikely to save any lives.

Institute of Policy and Planning Sciences
University of Tsukuba                    Tennodai 1-1-1 Tsukuba 305-8573 JAPAN
               Ask not how you can "do" free software business;
              ask what your business can "do for" free software.